Latest Paradigm Biopharmaceuticals (ASX:PAR) News
Page 1
Page 1 of 5
Independent review revives Paradigm’s case for a new iPPS trial outside the US
19 Nov 2026
Market Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Healthcare Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Paradigm trial fails futility test as administration enters its next phase
30 Oct 2026
Paradigm creditors get three more months before the next insolvency decision
28 Oct 2026
Market Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Healthcare Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Market Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Healthcare Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Paradigm finds regional iPPS benefit, but administration leaves Phase 3 future uncertain
15 Oct 2026
Market Wrap - Week 40 (28 Sept -> 2 Oct) 2026
3 Oct 2026